IP Library Granted Patent US 7,045,299
Granted Patent B2
US 7,045,299 · App. 10/333,192 · Granted May 16, 2006

Physiologically active peptide and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,045,299
App. No.
10/333,192
Granted
May 16, 2006
Kind
B2
Abstract

The present invention intends to provide a novel peptide and use thereof. More particularly, the present invention provides a novel peptide and a DNA encoding the same, a drug comprising the peptide or DNA, a screening method/screening kit for a compound or its salt that promotes or inhibits the activity of the peptide, a compound or its salt obtained by the screening, a drug comprising the compound or its salt, etc. The peptide of the invention and the DNA encoding the same are usable, e.g., for the diagnosis, treatment, prevention, etc. of digestive diseases, etc. Moreover, the peptide of the invention is useful as a reagent for screening a compound or its salt that promotes or inhibits the activity of the protein of the invention.

Claims (2)

1. A method of screening a compound or its salt that alters the binding properties between an isolated peptide containing the amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 21 or salt thereof, and a protein containing the amino acid sequence of SEQ ID NO: 1 or salt thereof, which comprises using an isolated peptide containing the amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 21 or salt thereof and a protein containing the amino acid sequence of SEQ ID NO: 1, its partial peptide, or a salt thereof in a screening assay.

2. A method of screening a compound or its salt that alters the binding properties between an isolated peptide containing the amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 21 or salt thereof, and a protein containing the amino acid sequence of SEQ ID NO: 1 or salt thereof, which comprises comparing the binding properties between an isolated peptide containing the amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 21 or salt thereof and a protein containing the amino acid sequence of SEQ ID NO: 1, its partial peptide, or a salt thereof in a screening assay in the presence of a test compound with the binding properties in the absence of a test compound.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2005
From: OHTAKI, TETSUYA; MASUDA, YASUSHI; TAKATSU, YOSHIHIRO; WATANABE, TAKUYA; TERAO, YASUKO; SHINTANI, YASUSHI; HINUMA, SYUJI
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016803/0365 →
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2005
From: OHTAKI, TETSUYA; MASUDA, YASUSHI; TAKATSU, YOSHIHIRO; WATANABE, TAKUYA; TERAO, YASUKO; SHINTANI, YASUSHI; HINUMA, SYUJI
To: TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
Reel/Frame 016211/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2004
From: OHTAKI, TETSUYA; MASUDA, YASUSHI; TAKATSU, YOSHIHIRO; WATANABE, TAKUYA; TERAO, YASUKO; SHINTANI, YASUSHI; HINUMA, SYUJI
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 015158/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2003
From: OHTAKI, TETSUYA; MASUDA, YASUSHI; TAKATSU, YOSHIHIRO; WATANABE, TAKUYA; TERAO, YASUKO; SHINTANI, YASUSHI; HINUMA, SYUJI
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 014415/0834 →